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Newborns of all mammal species are dependent on passively acquired 
protection against infection in order to survive the change from the relatively 
safe intrauterine life to extrauterine life with its many risks of infection. Most 
infections occur during the postnatal phase, that is, the first 7-10 days of life 
(Bachmann 1980). Domestic animals can only acquire protection against 
infection through the intake of colostrum and milk which contain the neces-
sary antibodies. 
In these animals (horses, ruminants and pigs), immunoglobulins are not 
transported from the dam to the fetus via the placenta. 
The fetus is capable of actively producing antibodies, e. g. after intrauterine 
infection during the third trimester of gestation (Schulz 1973a, b; Wellman and 
Reblin 1972; Braun et aL 1973, Bachmann et al. 1975). However, the contact 
with an environment full of microorganisms usually represents the first 
experience of the newborn's immune system with foreign antigens. It is not 
until a few days later that the resulting primary response leads to the formation 
of antibodies in the newborn. These antibodies belong either to the IgM class 
(low affinity) or to the IgA class (secretory antibodies in local infections). But 
the formation of active immunity either occurs too late to afford protection 
against disease or is hindered by the existence of specific antibodies in 
colostrum and milk. Thus, active immunization is not possible at this age. 
In addition, the newborn possesses nonspecific defence mechanisms which 
are either transferred via maternal milk or evolve gradually in the body itself. 
These nonspecific antimicrobial factors form part of both the cellular and 
humoral immune responses. The nature and functions of these defence 
mechanisms in vivo are not yet fully known. During the neonatal phase they 
may perhaps play a subordinate role (Porter 1979) when compared with the 
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protective effect of passively acquired antibodies, since both specific and non-
specific defence systems of die newborn only begin to function fully between 
the 8th and 16th weeks of life (Schulz 1973). 
The first part of this review describes the origin, composition and phy-
siological role of maternal antibodies. The second part - concentrating mainly 
on catttfe a n d o ^ infectious 
diseases by active ünmunizatwn of pre^ant dams aimed at stimulating, 
enhancing and prolonging the secre^n of antibodies m rnilk. 
Immunoglobulins in mammary gland secretion 
Maternal antibodies can be transferred to the fetus not only by secretions of 
the mammary gland but also via the diaplacental route. The route of this 
transfer depends on the placental structure characteristic of each species. 
Horses, cattle, pigs and goats have a Placenta epithehochorialis impermeable 
to macromolecules, i. e. immunoglobulins. These mend species supply anti-
bodies to their offspring only via the secretions of the mammary gland. In 
carnivores (Placenta endotheUochorialis) most of the .maternal antibodies 
(90-95 %) are transferred to the offeprmg duOugb gland secretions; 
5-10% of passive irnmunity is traiaferreddiaplacentaliy. Carnivores, tiiere-
fore, hold an intermediate position. In contrast^  humans, monkeys and most 
rodents (Placenta haemochorialis) have a pronounced diaplacental transfer of 
immunity. These differences in placentatkra are also wfiect^ m 
tion of immunoglobuliii&inoolottru« - . 
In species without diaplacental transfer of immunoglobulin*, hi^h kveb of 
IgG and IgM are found in colostrum whereas trie ccw*ntrationof IgA is low. 
Newborns of these species absorb t k e i ^ 12 to 
36 hours of life via the mttstme, thi*s acq«rin^ 
provides systemic mimum'ty to the newborn if ^ is immune 
and (2) antibodies are essential foriimaaD%4^unst a pathogenv Colostral IgG 
originates mostly from serum (Bourne and Curtis 1973* Newby and öourne 
1977). This passage of IgG «munences itt lÜe precobstr»! p f e » ^ ^ j f f 
probably subject to lierhioiiaLcuo^ toscMbti^ef XgGm 
colostrum is higher than in serum, til cti*% m 
demonstrate a selective traraport raeciisi^^ 
for IgGi (Keniler et at 1975), IgA and φ Μ β ^ | * ^ 
and local productionin the mammary φ^χ^βϋ/^ψ^^φ^χ^^^. 
The colostrum of domestic anmublttttaiuiMli^^^ t ^ m c o i t i ^ 
far as immunoglobulins are concerned, « f ? sy, . ^ v « -r. ΐ 
Hie concentration oi.kamimt^Ai^ 
decreases drastically after a few days oJ|M&tioiW%^ 
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concentration is primarily due to the decline of IgG which is present only in 
small quantities. The concentration of IgA also decreases in absolute terms, 
but not as much as IgG. In the pig, IgA becomes the dominant immunoglobu-
lin of milk. At this stage, 90 % of IgA and 70 % of IgM are synthesized locally 
by plasma cells of the mammary gland. 
In species with diaplacental transfer of immunoglobulins (primates, rodents) 
and in cats and dogs secretry IgA, i. e., IgA produced in the mammary gland, 
is the main immunoglobulin in colostrum and milk. The concentration of IgG 
is only low. Although the total concentration of immunoglobulins declines 
considerably during the post-colostral period of lactation, qualitative changes 
do not occur. Secretory IgA remains the main immunoglobuHtt (Drife et al. 
1976). . -
Cattle and other ruminants, however, behave differently. In these species, 
IgA does not play a dorninant role either in active or in passive maternal 
immunity as compared to other species (Bourne 1977). According to Mach and 
Pahud (1978) and Newbyand Bourne (1977), IgGt is the predominant 
immunoglobulin in colostrum and milk. IgGj derives entirely from blood 
serum. Small quantities of IgG2, IgA and IgM have also been demonstrated in 
colostrum and milk; a proportion of these immunoglobulins are produced in 
the mammary gland. Ruminants behave similarly to other species including 
man in that their milk immunoglobulins rapidly drop a lew days post partum 
(Straub and Matthaeus 1978). Since more than 80 % of the immunogbbulms 
in colostrum and milk derive from blood serum, the local production of 
antibodies in the mammary gland appears to be of minor importance (Newby 
et al. 1982). It is unclear whether the so-called "gut-mammary link" * the 
migration of antigen-sensitized lymphocytes from Peyer*s patches into the 
mammary gland ~ oasts in rüminant» (Chang tt *1. 1981). However* thü 
mechanism probably also^occurs in ruminants although its funcrionis jjöt as 
pronounced as in other species. This assumption is supported by recent 
findings mat the secretion of antibodies m bovine milk can be stimulated and 
prolonged by parenteral mtmunizatioa of cattle which have already been 
sensitized mtesrina% (Snodgrass et al. 1980* Eichhorn 1981), whereas there is 
only a moderate rise of antibody titers in serum. These milk antibodies mainly 
belong to the IgGj class, ^-.vt.:,*.:;v>--/«"* . v . , *,< . > 
specks of mammals e » ^ a i ruininants, the presence of * * sufficient 
amount of IgA anübc^ii« pro tides p a ^ 
tract of the neonate. As a rulerlgA is<iu^^«t^siettf « proteases of the 
digestive tmt-^m IgG 1fimm and Bienenstock 1968), IgA neutralizes 
viruses (Bohl tt & \V72i T\ao\uts$ et «L t$77> and plays a role ktfce 
bacteriostatic mkmy of « ä k (Dolby and iMmt %979h Fotthermoiti by 
Φνάά^&ύΜίύ^ epithelial cells, specific IgA prevents tbe adhesion of 
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pathogenic microorganisms to these cells. The intestinal tract is thereby coated 
with a protective film (Heremans 1974). In cattle this role is taken over by 
Igd; similar to IgA of other species, IgG t is also resistant to proteases 
(Bourne 1977). Following an intestinal infection, pigs (and other species) 
secrete in milk specific IgA antibodies for at least two weeks (Hess and 
Bachmann 1981) whereas in cattle, antibodies against rotavirus, for example, 
can be demonstrated only during a short period of lactation (Woode et al. 
1975). In calves, specific colostral IgG and IgM confer protection against 
E, coli infection; IgA provides such protection only to a low extent (Logan et 
al. 1974). 
In the immunologically mature organism IgA is formed locally by plasma 
cells after antigen contact in the intestine and other mucosal surfaces. During 
the neonatal phase, IgM-forming plasma cells are found in the Lamina propria 
(Allen and Porter 1973). Both Ig classes act synergistically in milk (Porter 
1979). 
Characterizing the antibodies in mammary gland secretions, Adinolfi et al. 
demonstrated already in 1966 the secretion of antibodies mainly of the IgA 
class specific for antigens normally present in the intestine. A short time later 
Bohl et al. (1972) demonstrated that mainly IgG was found in mammary gland 
secretions after parenteral administration of TGE virus while enteral infection 
resulted in the increased production of IgA. The authors postulated that the 
migration of antigen-sensitized lymphocytes from the intestinal wall into the 
mammary gland was responsible for the enhanced secretion of specific IgA 
antibodies. This hypothesis was confirmed by further investigations: in the pig 
(Bohl and Saif 1975; Hess et al. 1978; Evans et al. 1980), in man (Goldblum et 
al. 1975), and in some rodent species (Michalek et al. 1976; Roux et al. 1977). 
These results led to the development of a diagram which is generally accepted 
today, showing the migratory cycle of IgA-producing cells after antigen 
contact in all mammals except ruminants (Fig. 1). 
Precursors of IgA-producing B-lymphocytes are resting in the Peyer's 
patches of the intestine until they are sensitized by antigens entering the 
intestine. After antigen contact these cells migrate into the mesenteric lymph 
nodes, differentiating into blast cells. The blast cells then travel through the 
lymph system and finally enter the blood stream via the Ductus thoracius. 
While precursors of IgG and IgM-producing cells mainly settle in the spleen 
and peripheral lymph nodes (McDermott and Bienenstock 1979), cells com-
mitted for IgA synthesis predominantly home to the Lamina propria of the 
mucosae and basal membranes of exocrine glands. Although this so-called 
"homing" appears to be independent of the presence of specific antigen in the 
target organ, it is greatly stimulated by antigen contact (Husband and Watson 
1978). At the end of the gestation period a large proportion of blast cells 
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IgA- and IgM- t 0 , a m p r o p r i a 
producing cells to other mucosae 
Fig. 1 - Diagrammatic representation of the migration of IgA-producing lymphocytes from the 
Peyer's patches of the intestine to the mammary gland and other secretory organs (after Roux et al., 
1977). 
Precursors of IgA-producing lymphocytes remain inactive in the Peyer's patches (PP), where they 
are sensitized by enteral antigens. They then migrate into the mesenteric lymph nodes, where they 
differentiate into blast celh, eventually entering the peripheral blood through the d. thoracicus. 
Finally, these cells home on the I. propria of the intestines (LP) and on the basal membranes of 
exocrine glands. The migration to the mammary gland is probably hormone-controlled. 
migrate under hormonal control to the mammary gland (Weisz-Carrington et 
al. 1978; McDermott et al. 1981). At this stage they acquire full immunological 
maturity and provide the neonate with passive, immune protection through 
the secretion of IgA antibodies specific for enteral pathogens. 
The mucosal secretory immune system may also be active in other target 
organs. The so-called "remote site" stimulation includes not only the lympha-
tic tissue associated with the intestine as well as the mammary gland, but also 
the bronchus-associated lymphatic tissue and immunocompetent elements in 
the mucosae of the genital tract, the salivary glands, the respiratory tract and 
the pharynx (Bienenstock et al. 1979; Ogra et al. 1982). It is assumed that 
primary antigen contact is followed by local production of secretory anti-
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bodies (Montgomery et iL 1978; Rudzik et al. 1975). Moreover, after Stimula-
tion of the lymphatic tissue of the intestine and/or respiratory tract precursor 
cells can migrate to all other mucosae in the body. Thus, for example, oral 
immunization with a Streptococcus mutans vaccine in rats and man leads to the 
formation of specific IgA antibodies in the intestine and saliva (Arnold et al. 
1976; Michalek et al. 1976; Mestecky et al. 1978; Rudzik et al. 1975). These 
results however, are in contrast to those obtained by Saif and Bohl (1977) after 
infecting the respiratory tract of gravid sows with Pseudorabies virus and the 
virus of transmissible gastroenteritis. Secretion of specific IgA antibodies in 
milk could not be demonstrated in these studies. Therefore, at this stage it is 
not possible to make any conclusive statements concerning the function of the 
mucosal immune system as a whole. 
Cells and nonspecific factors in mammary gland secretions 
A great variety of cells are secreted with colostrum and milk. B- and T-
lymphocytes, macrophages and neutrophils have so far been identified. How-
ever, considerable uncertainty exists as to their function, particularly in 
domestic animals (Newby et al. 1982; Keller et al. 1981). The activities 
mediated by the cells in mammary gland secretions include stimulation of 
phagocytosis, spontaneous cell-mediated cytotoxicity and the formation of 
interferon (Kent and Newboult, 1969; Lawton and Shortridge 1977). The 
phagocytic activity of colostral leukocytes, however, is lower than that of 
blood leukocytes (Pickering et al. 1980). Immunocompetent cells present in 
mammary gland secretion have specific protective functions. The lymphocytes 
in milk consist of 50 % T-cells, 30 % B-cells and 20 % "null" cells (Ogra and 
Ogra 1978). IgG, IgM and IgA have been demonstrated on the surface of B-
cells, although hitherto it has only been possible to follow the course of IgA 
synthesis in vitro (Murello and Goldman 1970, Ahlstedt et al. 1975). In man, 
there are indications that IgA-producing colostral lymphocytes contribute to 
passive, local immunity in the digestive tract of the suckling infant (Walker 
1975) . Other evidence suggests that cellular immune factors are transferred to 
the suckling animal (Schlesinger and Covelli 1977). The successful in vitro 
stimulation of lymphocytes from colostrum and milk with specific antigens or 
mitogens demonstrates that these cells are immunologically active; their lower 
reactivity compared with peripheral lymphocytes suggests that there may be 
different types of cell populations (Smith and Schulz 1977, Parmelev et al 
1976) . 7 
Although free interferon is not demonstrable in milk, it is possible to 
stimulate its production m milk lymphocytes (Lawton and Shortridge 1977 
Keller et al. 1981). A number of factors, which have been found in milk and 
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colostrum, are capable of reinforcing the effect of maternal antibodies in their 
protective capacity (Sabin and Fieldsteel 1962, Matthews et al. 1977, Welsh 
and May 1979). For example, trypsin inhibitors and other still undefined 
factors facilitate the adsorption of immunoglobulins in cattle and man (Balfour 
and Comlin 1962). The proliferation of numerous viral and bacterial infectious 
agents is inhibited in vitro by lipids in milk, lysozyme, lymphokines and other 
undefined macromolecules (Falker et al. 1975, Welsch et al. 1978, Matthews et 
al. 1981, Toluhisa et al. 1981). For instance, lysozyme, which splits peptidog-
lycans of bacterial cell walls, exhibits a bacteriolytic effect in combination with 
specific antibodies. Lactoferrin, on the other hand, has a bacteriostatic effect, 
partly by withholding iron from microorganisms. In addition, the so-called 
lactobacillus factor promotes the growth of L. bifidus in the intestine of the 
newborn. This agent produces acetic and lactic acid, which inhibit the prolifer­
ation of E. coli (Bailabriga et al. 1975). In the pig, the membrane of the milk-
fat globules possesses a receptor for the E. coli antigen Κ 88, which may, in 
combination with specific antibodies, effectively inhibit the adsorption of 
Κ 88-positive strains (Porter 1979). In human colostrum, substances other 
than immunoglobulins have been shown to exhibit an inhibitory effect on 
infections with rotavirus, E. coli enterotoxin, influenza and syncytial viruses 
(Otnaess and Orstavik 1981, Shortridge and Wong 1976, Toms et al. 1980). 
Farm animal studies of this kind of activity are only beginning. Increasing 
knowledge of these factors will promote future understanding of the effects of 
non-specific antimicrobial activities in maternal milk. 
Cumulation of antibodies in the mammary gland 
Experiments in stimulating or prolonging antibody secretion in milk have 
been conducted in several species. In principle, two methods of antigen 
administration are possible: parenteral (subcutaneous or intramuscular) and 
local application. The second method focuses on oral and intramammary 
administration of the antigen. 
Oral administration - except in cattle - offers the best prospects of practical 
use. The basis for this is represented by the gut-mammary link whereby 
infection of the intestinal tract leads to local stimulation of precursor cells. At 
the onset of lactation, these cells (under hormonal control) produce antibodies 
in the mammary gland. Experiments with pathogens, which usually infect the 
digestive tract, were highly successful in pigs, rats, mice and man (Bohl et al. 
1972, Bohl and Saif 1975, Hess et al. 1980, Goldblum et al. 1975, Michalek et 
al. 1976, Roux et al. 1977). Antigen replication in the intestinal tract is 
important since inactivated antigens show hardly any effect (Evans et al. 1980). 
This type of immunization is well suited to induce high antibody titers in the 
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colostrum and during the postcolostral phase. The newborn thus attains 
systemic and local immune protection. As already mentioned, local immuniza-
tion via the respiratory tract does not lead to stimulation of secretory anti-
bodies against Aujeszky viruses and TGE viruses in the mammary gland (Saif 
and Bohl 1977). 
Following intramammary application of antigens, the formation of both 
specific IgA and IgG was demonstrated in rabbits (Genco and Taubman 1969), 
guinea pigs (McDowell 1973), pigs (Bohl et al. 1972, Djurickovic and Thorsen 
1970, Bourne et al. 1975, Chidlow and Porter 1977), cattle (Kerr et al. 1959, 
Hilpert et al. 1974) and sheep (Lascelles and McDowell 1970). These results 
lead to the conclusion that the synthesis of antibodies stimulated by intramam-
mary administration occurs mostly in the mammary gland. Onset of antibody 
production is quite rapid (Sarwar et al. 1964) in the gland's vaccinated and 
nonvaccinated sections and in the serum (Sarwar et al. 1964, Djurickovic and 
Thorsen 1977). 
Intramammary vaccination is rarely employed despite its obvious advan-
tages and successful results. It also does not play an important role in more 
recent developments of maternal vaccines. Although the reasons for this 
disinterest are numerous, intramammary vaccination is not employed mainly 
because of the high risk of infections associated with it and the large amount of 
work entailed. At present, it would not be feasible to put intramammary 
vaccination into practical operation. 
Parenteral administration generally results in the production and stimulation 
of serum antibodies. The origin of antibodies in colostrum and milk makes it 
clear that this type of immunization leads to the stimulation or boostering of 
antibodies secreted in colostrum. Colostral antibodies in farm animals derive 
mainly from blood serum, and recent experiments with specific antigens 
resulted in the stimulation of IgG antibody secretion in colostrum and milk 
(Bohl et al. 1975, Wells et al. 1978, Chidlow and Porter 1977). The amount of 
antibodies secreted decreases rapidly during the postcolostral phase. This type 
of immunization induces passive, systemic protection in the newborn pro-
vided that there is a sufficient amount of colostrum intake and antibody 
adsorption. However, results of previous studies have shown that parenteral 
immunization not only induces systemic immune protection, but also pro-
motes the production of secretory antibodies under certain conditions. 
Svennerholm et al. (1977) observed that parenteral (subcutaneous) immuniza-
tion of women who had antibodies against Vibrio cholerae after natural 
infection, led to a rise in specific IgA antibodies in their milk and saliva. 
Seronegative women were observed having no specific IgA antibodies even 
after receiving two subcutaneous vaccinations; however, there was a signific-
ant increase in the amount of serum antibodies (Svennerholm et al. 1980). 
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These results clearly indicate the possibility of a combined local/parenteral 
vaccination or parenteral booster vaccination after natural infection or enhanc-
ing the antibody secretion in milk. 
Experiences with dam immunization in practice 
As discussed above, the newborn can acquire immune protection after 
intake of antibodies in mammary gland secretion in two ways. First, systemic 
immunity to generalized infections is transferred through high antibody titers 
in colostrum if the latter is absorbed in sufficient quantities. However, 
circulating antibodies have no effect on pathogens of strictly localized infec-
tions such as enteropathogenic viruses or bacteria. Therefore, in order to 
provide the newborn with immunity continuous oral intake of antibodies is 
necessary during the period in which the newborn is most susceptible to 
infection, i. e. 14-21 days post partum. The enhanced secretion of specific 
antibodies must be prolonged into the postcolostral phase. Experiments with 
E. coli infections in the calf depict the situation described above very well. 
Logan and Penhale (1979a, b) administered colostral antibodies to calves 
intravenously and were thus able to provide protection against the septicemic 
form of E. coli enteropathy, but not against the enterotoxic form involving 
E. coli. However, continuous feeding of colostral or milk antibodies beyond 
the stage of mucosal permeability resulted in immunity to enteric infections of 
E. coli (Logan et al. 1974) and also to rotavirus (Woode et al. 1975). Similar 
observations were made in man (Hanson and Winberg 1972), swine (Haelter-
man 1965, Svendsen and Wilson 1971, Nagy et al. 1976) and sheep (Fahey et 
al. 1981) after intake of antibody-containing colostrum and milk followed by 
intestinal infections with various pathogens. 
With respect to active immunization of the dam, most results available 
concern local, passive immunization against infections caused by enteropatho-
gens. This type of immunization is aimed against pathogens with a ubiqui-
tous occurrence and against which a large percentage of the population already 
possesses antibodies from a natural infection, e. g., E. coli and rotaviruses in 
cattle, swine and sheep, or Coronavirus« in cattle. Immunization against 
infections caused by such pathogens must therefore be regarded as a booster 
immunization. Such results were obtained by Svennerholm et al. (1977,1980), 
who demonstrated that parenteral immunization can stimulate secretion of 
antibodies in colostrum and milk if the organism has already been naturally 
infected via the intestinal tract. A combined oral and parenteral vaccination 
may be successful in cases where the animal to be vaccinated has not yet had 
any antigen contact. For an efficient parenteral immunization, the vaccine 
must contain a sufficient amount of antigen and must be administered with 
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adjuvants (Myers 1980, Hess et al. 1981, Snodgrass et al. 1980). Subcutaneous 
and intramuscular administration are both effective (Bagley and Call 1979). 
Recent results claiming that merely the administration of adjuvant enhances 
the secretion of specific rotavirus antibodies in colostrum and milk could thus 
far not be substantiated (Eichhorn 1981). 
Passive, local immunization against infections of the intestinal tract 
The first attempts to control diarrhea in newborn animals by immunization 
of the dam were carried out with enterotoxigenic Escherichia coli (ETEC) 
infections. Since ETEC-monoinfections lead to severe illness only during the 
first few days of life (Moon et al. 1976, Smith and Halls 1967) and passively 
transferred antibodies inhibit the adsorption of the bacteria in the small 
intestine (Morris et al. 1980), the stimulation of antibody secretion in colos-
trum and milk only provides effective immune protection for a few days 
(Moon 1981, Acres et al. 1982). In cattle, immunization of the dam via the oral 
route plays a minor role because of the omasum system and the resultant 
dilution of the antigen. Earlier, parenteral immunization was carried out with 
herd-specific vaccines (Myers, 1976) because of the considerable number of 
subtypes. Since Guinee et al. (1976) and Moon et al. (1976) demonstrated that 
most of the ETEC bacteria isolated from calves carry the pilus antigen Κ 99 on 
their surface, vaccines now used contain Κ 99 antigens. The efficacy of this 
product has been demonstrated in various experiments. Calves of cows which 
have been immunized with vaccines containing Κ 99 were immune to orally 
administered doses of Κ 99 + ETEC, whereas calves of non-immunized cows 
regularly became ill. To stimulate antibodies to Κ 99 various vaccine prepara­
tions were used, e. g. highly or partially purified Κ 99 antigen (Acres et al. 
1979, Contrepois et al. 1978, Nagy 1980), Κ 99-bearing enucleated whole 
ETEC (Acres et al. 1979) and bacterins derived from inactivated whole 
bacteria (Acres et al. 1979, 1982; Bagley and Call 1979, Myers 1980, Con­
trepois et al. 1978). Usually these vaccines were administered either subcutane-
ously or intramuscularly. Two immunizations during the last trimester of 
gestation are recommended at an interval of 20-28 days. Optimal results were 
obtained when the second immunization was made between 7 and 40 days 
before term (Acres et al. 1982). The main aim of these immunizations is to 
achieve control of ETEC infections shortly after birth. 
After the demonstration that specific antibodies locally present in the 
intestine protect lambs and calves against viral diarrhea (Woode et al. 1975, 
Snodgrass and Wells 1976, 1978), experiments on the prophylaxis of such 
diseases by immunization of dams were initiated. Most of these experiments 
were performed with rotaviruses. Gravid animals (cattle and sheep) were given 
Active Immunization of the Dam 33 
intramuscular or subcutaneous vaccinations with inactivated or live bovine 
rotavirus and adjuvants which resulted in enhancing and prolonging the 
secretion of specific rotavirus antibodies in milk (Snodgrass et al. 1980, 
Bachmann 1980, Eichhorn 1981, Hess et al. 1981) and sheep (Wells et al. 
1978). Snodgrass et al. (1980) conducted experimental rotavirus infections in 
calves of vaccinated dams and non-vaccinated control dams. They observed 
prolonged incubation and prepatent periods whereas clinical features were 
identical to controls. 
The first clinical results of a commercial, combined vaccine (rota- and 
Coronavirus) were recently published (Kunz 1982). The vaccine was tested at 
five farms on a total of 119 animals of which 40 developed diarrhea. In four 
herds vaccination lowered the incidence of diarrhea from 84-100 % to 
15-36 %, but only to 70 % in the fifth herd. In three herds, mortality was still 
8%. 
The results of recent experiments indicate that the rapidly developing age 
resistance against infections by ETEC Κ 99+ can be broken with the simul­
taneous infection of ETEC Κ 99+ and rotaviruses. Combined ETEC Κ 99+ 
and rotavirus infections cause severe diarrhea even in older calves (Snodgrass et 
al. 1982, Tzpipori et al. 1981, Gouet et al. 1978, Hess et al. 1982). Rotavirus 
infections in calves aged between 5 and 14 days are often associated with 
ETEC infections (Baljer and Bachmann 1980, Moon et al. 1978). Since it is 
possible that rotavirus infections are also associated with other pathogens such 
as bovine corona- and parvoviruses (Stair et al. 1978, Storz and Bates 1973, 
Bachmann and Hess 1982) combined vaccines should be used for immuniza­
tion of the dam to protect calves from diarrhea. First steps towards this goal 
were done by our group with the development of a combined E. coli Κ 99+/ 
rotavirus vaccine. The vaccine consists of partially purified Κ 99 antigen and 
rotavirus immune complexes, which are absorbed on aluminium hydroxide 
and mixed with adjuvants. This preparation is administered subcutaneously 
twice at 4-week intervals during the last trimester of gravidity; after inocula­
tion the presence of rotavirus antibodies (Eichhorn 1981, Hess et al. 1981) and 
Κ 99 antibodies (Bachmann et al., unpublished results) can be demonstrated in 
milk for at least 21 days. In a recent field study with 170 animals the incidence 
of diarrhea was reduced from 50-60 % (in the years before vaccination) to 
approximately 15-20 %; the mortality rate declined from 10 % to 0.6 % 
(Eichhorn et al. 1982). At present, a modification of this vaccine additionally 
containing bovine parvo- and coronaviruses is used in a larger study. 
There are a number of publications on immunization of sows for passive 
local protection against diarrhea. The first successful experiments were carried 
out with oral immunization of gravid sows, using live Escherichia coli (ETEC) 
bacteria (Rutter and Jones 1974, Kohler 1975). On the basis of these studies, 
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oral ETEC vaccinations with live bacteria were put into general practice. 
Although the efficacy of such vaccines is good (Kohler 1978), they cannot be 
recommended because of the excretion of pathogens. A further disadvantage is 
that only herd-specific vaccines can be used. Oral immunization of dams using 
inactivated ETEC strains does not contribute to the spread of pathogens. 
However, large doses of bacteria, which must be administered over a fairly 
long period of time, are required to achieve effective passive immunity. Thus, 
for example, the administration of 1013 inactivated ETEC bacteria was ineffec-
tive, whereas the administration of 1011 live bacteria resulted in high antibody 
titers; both the inactivated and live bacteria were administered over a period of 
three days (Moon 1981). Porter and Chidlow (1979) administered 2 Χ 109 
heat-inactivated £. coli daily from the 50th day of gestation until parturition. 
Their observations, however, showed only slightly higher antibody titers in 
colostrum compared with those of control animals. Piglets were not immune 
to experimental infections. Nevertheless an additional parental injection of 
4 x 1010 heat-inactivated bacteria led to a marked rise in Ο antibody titers; 
specific activity was found in the IgM class. The mortality rate of infected pigs 
was 2 % compared with 76 % of the control animals. The precise mechanism 
for the passive immune effect after oral immunization with E T E C is not 
known. 
More recent investigations ascribe the passive effect to the inhibition of 
adhesion by fimbria- (pilus) antigen-specific antibodies (Moon 1981). Three 
adhesion factors (similar to that of the calf) designated as Κ 88, Κ 99 and 
987 Ρ, are known in the pig. Additionally, toxins produced by E T E C have 
been introduced experimentally in the immunization of sows against E. coli. 
The toxins used are a thermolabile (LT) and a thermostable (ST) enterotoxin. 
In pigs, immunization of the dam today is normally carried out with 
vaccines containing pilus antigens. The efficacy of these pilus vaccines has been 
demonstrated in various studies (Rutter and Jones 1973, Nagy et al. 1976, 
1978; Rutter et al. 1976; Morgan et al. 1978; Moon 1981). However, this 
passive protective effect is entirely restricted to the pilus antigen used in each 
case (Morgan et al. 1978). This fact must be taken into account when 
employing the Κ 88 vaccines available commercially even if these vaccines 
cover a high percentage of the ETEC strains occurring in suckling pigs. 
Unfortunately, there are still no studies available on bi- or trivalent pilus 
vaccines, which could cover virtually all relevant E T E C strains in swine 
(Moon 1981). However, this is where future possibilities lie. 
£. coli toxoid vaccines, which are manufactured from inactivated LT, are 
administered together with oil adjuvants twice via the intramammary and/or 
intramuscular route (Dobrescu and Huygelen 1976, Dorner et al. 1980). 
Morbidity after experimental infection was thereafter reduced from 94 % in 
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the control animals to 48-61 % in the piglets of vaccinated sows; mortality 
was reduced from 51 % to 5 %. Similar results were obtained after parenteral 
vaccination of sows with cholera toxin, which is antigenically related to LT 
(Dorner et al. 1980). Fuerer et al. (1982) used procholeragenoid (a derivative of 
cholera toxin) for immunization of gravid sows. In a field study, morbidity 
was thus reduced from 73 % to 11 % and mortality declined from 4.7 % to 
0.77 %. After use of this vaccine, the specific activity of antibodies in 
colostrum is thought to be mainly associated with the IgA class as in the case 
with toxoid vaccines. However, the general use of toxoid vaccines is not 
recommended until further studies are available, since a number of ETEC 
strains in piglets only produce ST and not LT and conflicting reports exist on 
cross immunity between LT and ST (Smith and Gyles 1970, Dobrescu and 
Huygelen 1976). 
There are also contradictory results from experiments on the development 
of vaccines for sows against transmissible gastronenteritis (TGE). TGE infec-
tions in suckling pigs cause diarrhea with a mortality rate of up to 100 %. 
Although adult animals may also fall ill, the course of infection is considerably 
more mild. The litters of sows that have suffered an infection before or during 
gestation are protected by the uptake of secretory antibodies in milk. In 
colostrum, specific antibody is found in the immunoglobulin classes IgA and 
IgG; in milk, such activity is almost exclusively in the IgA class (Bohl et al. 
1972, Saif et al. 1972, Abou-Youssef and Ristic 1972). Oral administration of 
attenuated virus strains is the method chosen to induce passive oral immuniza-
tion against TGE because intramuscular administration does not lead to 
stimulation of IgA antibodies in milk (Bohl et al. 1975). 
"Immunization" using virulent pathogens by feeding gravid sows with 
intestinal contents of infected piglets was recommended a long time ago 
(Hooper and Haelterman 1966). This method was effective, but nonetheless, 
because of the spread of virulent pathogens it must be judged as dangerous as 
oral vaccination with live E. coU strains. Bohl and Saif (1975) and Morula et al. 
(1976) used TGE virus attenuated in pig kidney cell cultures for oral immuni-
zation of sows, but they could not induce passive protection of piglets. 
According to Bohl and Saif (1975), specific antibody activity was found mainly 
in the IgG class and after a short period of lactation it falls drastically. 
The TGE strain CKp, also attenuated in pig kidney cell cultures, was 
developed in Hungary and it produced considerably better results. After 
immunizing the dam with this strain, good passive immune protection 
developed in piglets. Unfortunately, experimental test infections were not 
conducted in diese studies (Csontos et al. 1973, Benyeda and Moscari 1974, 
Moscari et al. 1975). Woods (1978) describes a TGE virus vaccine that is highly 
interesting as far as its biological properties are concerned. The vaccine strain 
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used is a small plaque variant of the Miller TGE virus strain attenuated in a 
leukocyte cell line. This variant is not pathogenic for 3-day-old piglets. The 
virus also seems to have an altered cell tropism. After infection of newborn 
piglets, the presence of the virus is not demonstrated in villous epithelial cells 
(as is the case with virulent TGE virus) but in unidentified cells of the Lamina 
propria (Woods et al. 1981). In two experiments, gravid sows were immunized 
twice with this virus. In piglets which had taken up colostrum and milk from 
these sows, mortality after experimental infection with a virulent TGE strain 
was only 14 % and 29 % respectively (Woods 1978, Woods and Pedersen 
1979). Further reports are not available. 
One of the vaccines developed by our research group is a TGE strain 
(B1-300) that has been attenuated in pig thyroid cells. This strain exhibits only 
weak pathogenicity for piglets (Hess et al. 1977). After administration to adult 
sows and young pigs, the vaccine virus can be demonstrated in the villous 
epithelia of the middle and distal jejunum; however, its presence cannot be 
demonstrated in feces or in nasal secretion (Hess et al. 1980). After two oral 
administrations of the virus in acid-resistant capsules, specific antibody activ-
ity was found in the IgA class (Bachmann and Hess 1978). Experimental test 
infections were conducted with the virulent Miller virus strain. The mortality 
of control animals after infection on the 3rd day of life was 100 %; among 
piglets which had ingested colostrum and milk of vaccinated animals mortality 
was only 10 % (Hess et al. 1978). Only mild or moderate diarrhea was 
observed in piglets from vaccinated sows. It is possible that full immunologic 
protection can be obtained in piglets by raising the titer of the vaccine. Studies 
are still pending. Up until now, this vaccine has been tested only under 
experimental conditions. Two problems must be solved before the vaccine can 
be put into general application. First, the virus vaccine has to be propagated in 
pig thyroid cells, which are difficult to culture. Secondly, the virus has to be 
administered in acid-resistant capsules, using an appropriate instrument. This 
form of administration is not suitable for general use, but since the vaccine 
virus is labile at low pH values (Hess and Bachmann 1976) it must be protected 
against gastric juices. 
Attempts to obtain lactogenic immunity via intramuscular injection of 
attenuated TGE virus strains only led to a slight reduction of mortality of 
90-45% (Bohl et al. 1975, Hess et al. 1978). Kaji and Shimizu (1978) 
succeeded in providing 100 % protection in piglets by immunizing the dams 
via the intramuscular route with high doses of an attenuated TGE strain 
followed by intranasal boosters. Yet further studies are necessary because tests 
were only performed on a small number of sows. Leopoldt et al. (1975) also 
used an attenuated TGE vaccine administered intramuscularly. It was possible 
to reduce mortality to 13% after administering the so-called Riems TGE 
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vaccine in herds that had suffered TGE infections. However, virtually all the 
animals already had TGE antibodies in serum before immunization. Thus, 
these conditions are fundamentally different compared to the experiments 
already described for which only seronegative animals were used. The value of 
such parenteral immunizations lies in the fact that they control clinical 
morbidity in herds that had already been infected (Bohl and Saif 1981). When 
TGE infections are freshly introduced into a herd, parenteral vaccinations have 
hardly any effect. 
Unlike vaccinations of sows with ETEC to provide oral passive immuniza-
tion of piglets, TGE immunization of the dam has not yet advanced to the 
point where it can be put into general use. Further research in this field is 
necessary, particularly in view of the multiple etiology of viral diarrhea in 
swine. Other viruses, e. g. another Coronavirus - the causative agent of 
epizootic virus diarrhea (EVD) (Chasey and Cartwright 1976, 1978; Pensaert 
and DeBouck 1978), rotaviruses (Woode et al. 1976, Bachmann et al. 1979) 
and pararotaviruses (Bohl et al. 1982, Bridger et al. 1982) can cause diarrhea in 
mono- and mixed infections. Thus, immunization against TGE alone would 
not bring about the desired success and attempts must be made to develop 
combined vaccines. Further studies should be encouraged by the fact that -
similar to the situation in cattle - antibody secretion in milk can be enhanced 
by intramuscular administration of virus antigens in animals that have already 
been naturally infected with rotavirus via the intestinal tract. 
Passive systemic immunization against general infections 
Another possibility for immunization of the dam is to provide the offspring 
with passive, systemic immunization against general infections. Until now not 
much attention has been given to this method as far as large animals are 
concerned. However, passive systemic immunization has been quite successful 
among poultry: chicks are passively immunized via the egg-yolk against 
infectious bronchitis, Gumboro disease and avian encephalomyelitis (Sieg-
mann 1979). For cattle, no results are available. Yet the method might well be 
suitable for immunizations against the septicemic form of E. coli enteropathy, 
IBR-IPV infection and bovine viral diarrhea (BVD). However, die availability 
of inactivated vaccines would be necessary since live vaccines could cause fetal 
damage. In swine, immunization of the dam is carried out against Pseudorabies 
in piglets. After infection of susceptible newborn piglets mortality is 100 %. 
The mortality rate declines continuously with progressing age: infection 
during the 10th week of life only leads to 2 % mortality and efficient active 
immunity is not expected before the 14th day of life when antibodies of the 
IgG class are demonstrable (Browne and Bourne 1976). Sows immune to 
Pseudorabies virus (Aujeszky's disease) secrete antibodies in the colostrum. 
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These antibodies protect piglets against infection if they ingest sufficient 
quantities of colostrum in time. This holds true regardless of whether the sows 
were naturally infected (McFerran and Dow 1973) or vaccinated. In general, 
vaccines from inactivated pathogens are just as suitable as those containing 
attenuated virus (Zuffa 1964, Andries et al. 1978, Wittmann and Jakubik 
1979), although the latter is preferred. 
Immunization of the dam is also carried out against bacterial infections of 
piglets. Bergeland (1975) describes immunization of sows against necrotic 
piglet enteritis caused by Clostridium perfringens Type C. Endemic outbreaks 
of the disease occurred in pig populations. Therefore, sows were vaccinated 
twice 5 and 2 weeks before term with C. perfringens Type C toxoid in order to 
stimulate high colostral antibody titers for effective passive immunization. 
Amtsberg (1978) recommends immunization of the dam also against exudative 
epidermatitis in piglets caused by Staphylococcus hyicus. The vaccine used is a 
formalin-inactivated suspension of bacteria, and it is administered twice at an 
interval of 17 days, approx. four weeks and one week before term. All the 
piglets of immunized sows were protected against subsequent infection. 
Immunization of the dam is also employed against erysipelas - a rare disease in 
piglets. Results, however, vary. 
Conclusions and prospects 
Immunization of the dam is recommended for protection against both local 
intestinal and systemic infections which occur in young animals during the 
first weeks of life. The advantage is that under normal conditions, when 
colostrum and milk are ingested, immune protection commences almost 
immediately. Our present experience indicates that this type of passive 
immunization is of greater practical importance for the complex of local 
intestinal infections than for protection against general infections. Future 
developments, however, may lead to the routine use of immunization of the 
dam for general infections as well. This possibility has been shown by studies 
on swine with vaccinations against Pseudorabies, necrotic enteritis and exsuda-
tive epidermatitis (Staph, hyicus). It is possible that such measures may be 
suitable also for other diseases. 
Disadvantages of immunization of the dam may be that antibodies trans 
ferred from the dam may influence the formation of active immunity in the 
newborn animal. Hitherto it has been postulated that passively supplied 
antibodies as a rule interfere with the active synthesis of antibodies (Uhr and 
Baumann 1961). Although this view has become somewhat differentiated 
today, it is certain that passively transferred antibodies generally do interfere 
with the formation of effective active immunity after initial vaccination. 
Cormier and Charley (1978) demonstrated that colostral antibodies inhibit the 
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primary response after immunization of piglets after swine fever. After test 
infections, however, a booster effect was observed, so that the initial vaccina­
tion did have some effect. There are similar observations in piglets which had 
passive antibodies against Pseudorabies virus and had been actively immunized 
(Andries et al. 1978). According to Wittman and Jakubik (1979), vaccinations 
of piglets passively immune against Pseudorabies are successful as early as the 
second week of life, although at this age the animals show high serum antibody 
titers. 
In calves with passive immunity to IBR-IPV virus and BVD virus, Brar et al. 
(1978) showed that an active immunization against BVD is possible even if 
serum antibody titers between 1:20 and 1:96 can still be demonstrated. 
Following immunization with IBR-IPV virus, on the other hand, no active 
antibody formation was observed in passively immune animals. In revaccina-
tions, however, it was demonstrated that the vaccinated animal had become 
sensitized, i. e. previously vaccinated animals developed higher antibody titers 
than those with only one vaccination. 
It has also been stated that maternal antibodies present locally in the 
intestinal tract exert an inhibitory effect on the formation of an active 
immunity. This effect is probably responsible for the low efficacy of oral 
vaccination against rotaviruses and coronaviruses in the calf (Buerki et al. 
1982, De Leeuw et al. 1980). Lambs fed with antibody-containing colostrum 
remained healthy after oral infection with rotavirus, but showed a serological 
reaction (Snodgrass and Wells 1978). Piglets fed with bovine colostrum also 
seroconverted after oral infection with rotavirus without showing any signs of 
sickness. From this it supposed that a subclinical infection occurs despite the 
protective effect of milk antibodies, and active immunity is built up (Bridger 
and Brown 1981), There is also a report from tests in piglets that local 
antibodies do not interfere with the active formation of antibodies against E. 
colt Ο antigens (Porter 1973). Similarly, serum antibodies do not appear to 
have an inhibitory effect in such cases (Watson et al. 1979). 
Clearly, these few examples do not allow any fundamental recommenda­
tions to be made. Also, there may be differences between species. Nonethe­
less, in the application of immunizations of the dam it must be taken into 
consideration that during active immunization of the newborn the develop­
ment of active immunity may be inhibited. 
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